Ernexa Therapeutics Inc. Entity Listing, Par Value Per Share
Ernexa Therapeutics Inc. (ERNA) reported Entity Listing, Par Value Per Share of $0.01 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-08-06
- Ernexa Therapeutics Inc. entity listing, par value per share for the quarter ending 2026-03-31 was $0.01, a 0.00% change year-over-year.
- Ernexa Therapeutics Inc. entity listing, par value per share for the quarter ending 2025-03-31 was $0.01.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month |
|---|---|---|---|
| 2026-06-30 | $0.01 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $0.01 10-Q · filed 2026-05-11 | ||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $0.01 10-Q · filed 2025-08-13 | ||
| 2025-03-31 | $0.01 10-Q · filed 2025-05-07 | ||
| 2024-09-30 | $0.01 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $0.01 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |